首页> 外文期刊>Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA >Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study
【24h】

Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study

机译:这是骨矿物密度监测的优选地点,作为常规临床实践中治疗相关的抗骨折效应的指标? 基于注册表的队列研究

获取原文
获取原文并翻译 | 示例
       

摘要

A Summary Change in total hip bone mineral density (BMD) provides a robust indication of anti-fracture effect during treatment monitoring in routine clinical practice, whereas spine BMD change is not independently associated with fracture risk.
机译:总髋骨矿物密度(BMD)的总结变化在常规临床实践中治疗监测期间提供了抗骨折效应的稳健指示,而脊柱BMD变化与骨折风险无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号